Rchr
J-GLOBAL ID:201101009391246924   Update date: Jan. 30, 2024

Yamada Suguru

Yamada Suguru
Research field  (1): Digestive surgery
Research keywords  (8): endoscopic surgery ,  oncology ,  pancreatic cancer ,  hepato-biliary-pancreatic cancer ,  transrational research ,  hepato-biliary-pancreatic surgery ,  clinical oncology ,  gastrointestinal surgery
Research theme for competitive and other funds  (11):
  • 2020 - 2023 A double-blinded RCT for investigating clinical efficacy of AHCC in patients with pancreatic ductal adenocarcinoma
  • 2019 - 2022 Tumor-educated platelets of pancreatic cancer cases from the viewpoint of EMT status
  • 2019 - 2021 腫瘍由来エクソソームによる膵癌マルチオミクス・プロファイリングの挑戦と臨床応用
  • 2017 - 2019 Metabolomics analysis for predictive biomarker discovery of Chemotherapy Efficacy in Esophageal Squamous Cell Carcinoma
  • 2016 - 2019 Novel treatment strategy of esophageal cancers by detecting the cancer cells with hybrid EMT potential in the thoracic lymph duct.
Show all
Papers (488):
  • Takamichi Igarashi, Suguru Yamada, Yui Hoshino, Kenta Murotani, Hayato Baba, Hideki Takami, Isaku Yoshioka, Kazuto Shibuya, Yasuhiro Kodera, Tsutomu Fujii. Prognostic factors in conversion surgery following nab-paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual-center study. Annals of gastroenterological surgery. 2023. 7. 1. 157-166
  • Kota Nakamura, Zhongxu Zhu, Souvick Roy, Eunsung Jun, Haiyong Han, Ruben M Munoz, Satoshi Nishiwada, Geeta Sharma, Derek Cridebring, Frederic Zenhausern, et al. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Gastroenterology. 2022. 163. 5. 1252-1266
  • Masaya Yamanaka, Masamichi Hayashi, Fuminori Sonohara, Suguru Yamada, Haruyoshi Tanaka, Akihiro Sakai, Shinji Mii, Daigo Kobayashi, Keisuke Kurimoto, Nobutake Tanaka, et al. ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9. Annals of surgical oncology. 2022. 29. 11. 7192-7193
  • Masaya Yamanaka, Masamichi Hayashi, Fuminori Sonohara, Suguru Yamada, Haruyoshi Tanaka, Akihiro Sakai, Shinji Mii, Daigo Kobayashi, Keisuke Kurimoto, Nobutake Tanaka, et al. Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9. Annals of surgical oncology. 2022. 29. 11. 7180-7189
  • 五十嵐 隆通, 木村 七菜, 山田 豪, 室谷 健太, 高見 秀樹, 渋谷 和人, 吉岡 伊作, 平野 勝久, 小寺 泰弘, 藤井 努. 切除可能境界膵癌における術前治療効果と術後予後因子の検討. 日本消化器外科学会総会. 2022. 77回. P193-3
more...
MISC (556):
Books (8):
  • 消化器癌の外科治療〈2〉肝・胆・膵-こんなときどうするQ&A 3-8.膵癌における腹腔洗浄細胞診 膵癌において腹腔洗浄細胞診断の意義について、陽性時は切除の適応がないのでしょうか?
    中外医学社 2018 ISBN:9784498043282
  • 消化器疾患の最新医療 (先端医療シリーズ49) 6.プラズマ照射液による癌治療
    先端医療技術研究所 2018 ISBN:9784925089616
  • 臨床外科 手術ステップごとに理解する 標準術式アトラス 2.胃・十二指腸 十二指腸腫瘍に対する切除術
    医学書院 2017
  • 新世代の膵癌診療・治療バイブル 5-2.門脈浸潤例に対する手術適応・手術手技
    メディカ出版 2017 ISBN:9784840461719
  • 臨床外科 消化器・一般外科手術のPearls & Tipsーワンランク上の手術を達成する技と知恵 9.膵臓 膵中央切除
    医学書院 2015
more...
Education (1):
  • - 1997 Nagoya University School of Medicine
Professional career (1):
  • 医学博士
Work history (1):
  • Nagoya University Lecturer
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page